ARS Pharmaceuticals (NASDAQ:SPRY) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here’s a quick overview of what investors should know before the release. Analysts are estimating that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.15. The announcement from ARS Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Overview of Past EarningsThe company’s EPS missed by …